Cargando…

Targeting the A(3) adenosine receptor to treat cytokine release syndrome in cancer immunotherapy

Cancer patients undergoing immunotherapy may develop cytokine release syndrome (CRS), an inflammatory cytokine storm condition, followed by neurotoxic manifestations and may be life-threatening. The current treatments for CRS successfully reduce the inflammatory response but may limit the anticancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Shira, Fishman, Pnina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363488/
https://www.ncbi.nlm.nih.gov/pubmed/30787591
http://dx.doi.org/10.2147/DDDT.S195294